Evaluation of dyskerin expression and the Cajal body protein WRAP53β as potential prognostic markers for patients with primary vaginal carcinoma
Affiliations: Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden, School of Health and Medical Sciences, Örebro University, Campus USÖ, 701 82 Örebro, Sweden, Department of Radiation Sciences, Umeå Universitet, 901 87 Umeå, Sweden, Department of Oncology, Örebro University Hospital, 701 85 Örebro, Sweden, School of Medical Sciences, Örebro University, 701 85 Örebro, Sweden, Department of Bioscience and Nutrition, Karolinska Institutet, 141 83 Stockholm, Sweden, Department of Oncology‑Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine, 03022 Kiev, Ukraine
- Published online on: November 23, 2021 https://doi.org/10.3892/ol.2021.13148
- Article Number: 30
Copyright: © Ranhem et al. This is an open access article distributed under the terms of Creative Commons Attribution License.